DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Gökbuget N. Dombret H. Bonifacio M. et al.
Long-Term Outcomes after Blinatumomab Treatment: Follow-up of a Phase 2 Study in Patients (Pts) with Minimal Residual Disease (MRD) Positive B-Cell Precursor Acute Lymphoblastic Leukemia (ALL).
Blood 2015;
126: 680
We do not assume any responsibility for the contents of the web pages of other providers.